Graney & King’s Medtronic MDT Stock Holding History

Graney & King’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.5K	Buy	179 +1	+0.6%	+$96	0.01%	215
2025 Q4	$17.1K	Buy	178 +1	+0.6%	+$97	0.01%	205
2025 Q3	$16.8K	Buy	177 +2	+1%	+$184	0.01%	197
2025 Q2	$15.3K	Buy	175 +1	+0.6%	+$85	0.01%	198
2025 Q1	$15.6K	Buy	174 +2	+1%	+$179	0.01%	191
2024 Q4	$13.8K	Buy	+172	New	+$14.9K	0.01%	194

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Graney & King's MDT Position: Q1 2026 in Review

Graney & King increased its Medtronic (MDT) stake by 0.56% in Q1 2026, buying an estimated $96 and bringing the position to 179 shares worth $15.5K. The position accounts for 0.01% of the portfolio, ranked #215.

Graney & King first reported a position in MDT in Q4 2024 and has held it in 6 quarters since. The position peaked at $17.1K in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Graney & King held 179 shares of Medtronic worth $15.5K as of Q1 2026.
Graney & King bought 1 Medtronic share in Q1 2026, an estimated $96.
Medtronic made up 0.01% of Graney & King's portfolio in Q1 2026, its #215 holding.
Graney & King first reported a position in Medtronic in Q4 2024 and has held it in 6 quarters since.
Graney & King's Medtronic position peaked at $17.1K in Q4 2025.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Graney & King's 13F filing for Q1 2026, filed 18 May 2026.